From Infection to Encapsulation; A Case Report on Encapsulating Peritoneal Sclerosis, Clinical Challenges and Management

Authors

Sidra Memon MD, Piedmont Macon Medical CenterFollow
Jacob Seth Psomiadis MD, Piedmont Macon Medical CenterFollow
Syed Uzair Mahmood, University of Texas Health Science Center at HoustonFollow
Jennifer Hoffman MD, Coliseum Medical CentersFollow

Author Credentials

Sidra Memon, MD

Seth Psomiadis, MD

Syed Uzair Mahmood, MD, MPH, CPH, FRSPH

Jennifer Hoffman, MD

Author ORCID Identifier

000-002-009-4161

Abstract

Encapsulating Peritoneal Sclerosis (EPS) is a rare but deadly sequlae of peritoneal dialysis resulting in intraperitoneal inflammation and fibrosis. The disease itself can present in a variety of ways and is associated with significant morbidity and mortality. Here we present the case of a man in his 50's with a history of chronic peritoneal aspergillus as well as end-stage renal disease on peritoneal dialysis that had multiple admissions for abdominal fluid collections as well as bowel obstruction. After a multidisciplinary approach, the patient was diagnosed with encapsulating peritoneal sclerosis and then started the recommended therapy of tamoxifen and prednisone.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Recommended Citation

Memon S, Psomiadis JS, Mahmood S, Hoffman J. From Infection to Encapsulation; A Case Report on Encapsulating Peritoneal Sclerosis, Clinical Challenges and Management. Advances in Clinical Medical Research and Healthcare Delivery. 2024; 4(4). doi: 10.53785/2769-2779.1238.